Alps Advisors Inc. cut its stake in PetMed Express Inc. (NASDAQ:PETS) by 6.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 22,727 shares of the company’s stock after selling 1,672 shares during the period. Alps Advisors Inc.’s holdings in PetMed Express were worth $426,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. NEXT Financial Group Inc boosted its stake in shares of PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock valued at $100,000 after buying an additional 3,350 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of PetMed Express by 101.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,206 shares of the company’s stock valued at $116,000 after buying an additional 3,121 shares during the last quarter. Cutler Group LP boosted its stake in shares of PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock valued at $132,000 after buying an additional 8,029 shares during the last quarter. Bank of Montreal Can purchased a new stake in shares of PetMed Express during the second quarter valued at about $143,000. Finally, Arizona State Retirement System purchased a new stake in shares of PetMed Express during the first quarter valued at about $184,000. Institutional investors and hedge funds own 75.97% of the company’s stock.
PetMed Express Inc. (NASDAQ:PETS) traded up 1.97% during trading on Friday, hitting $20.67. The stock had a trading volume of 514,790 shares. PetMed Express Inc. has a 52 week low of $15.61 and a 52 week high of $21.16. The company has a market cap of $417.12 million, a PE ratio of 19.69 and a beta of 1.07. The stock has a 50-day moving average price of $20.38 and a 200-day moving average price of $19.23.
PetMed Express (NASDAQ:PETS) last posted its earnings results on Monday, July 25th. The company reported $0.32 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.01. The firm had revenue of $72.50 million for the quarter. PetMed Express had a net margin of 9.09% and a return on equity of 25.97%. The company’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.29 earnings per share. Equities analysts predict that PetMed Express Inc. will post $1.11 EPS for the current year.
Several brokerages have issued reports on PETS. Zacks Investment Research cut PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 11th. Credit Suisse Group AG restated a “sell” rating and set a $13.00 price objective on shares of PetMed Express in a research note on Tuesday, August 16th.
In other PetMed Express news, insider Bruce S. Rosenbloom sold 8,000 shares of the stock in a transaction on Friday, August 12th. The shares were sold at an average price of $20.38, for a total transaction of $163,040.00. Following the transaction, the insider now directly owns 43,267 shares of the company’s stock, valued at $881,781.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Ronald J. Korn sold 4,000 shares of the stock in a transaction on Monday, August 1st. The stock was sold at an average price of $20.76, for a total transaction of $83,040.00. Following the transaction, the director now directly owns 75,333 shares in the company, valued at $1,563,913.08. The disclosure for this sale can be found here. Company insiders own 4.70% of the company’s stock.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express Inc. (NASDAQ:PETS).
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.